A. Ullrich

Molecular Biology · 2000–2008

A researcher in the Science corpus: 7 papers; trusts 5 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

Whom A. Ullrich trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. K. Frese
  2. J. Ludwig
  3. D. Tuveson
  4. John N. Weinstein

Who trusts A. Ullrich overall

  1. Ji Luo
  2. K. Strebhardt
  3. N. Ferrara

Papers from A. Ullrich's perspective

Ordered by how strongly the researchers A. Ullrich trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Anticancer drugs: To the rescue? (Nature reviews. Drug discovery)
  2. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. (Science)
  3. Proteomic Screen Finds pSer/pThr-Binding Domain Localizing Plk1 to Mitotic Substrates (Science)
  4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
  5. Assembly of Cell Regulatory Systems Through Protein Interaction Domains (Science)
  6. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
  7. Cancer genes and the pathways they control (Nature Medicine)
  8. Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL. (Cell)
  9. SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo. (Blood)
  10. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. (Journal of Clinical Investigation)

Their papers